Table 2 Mean VAS score, ODI score, and stability score before and after treatment in groups 1 and 2:.
Pre treatment | Post treatment | MD | 95% CI | % of change | p value | |
|---|---|---|---|---|---|---|
Mean ± SD | Mean ± SD | |||||
VAS | ||||||
Group 1 | 6.96 ± 1.21 | 2.56 ± 1.26 | 4.4 | 3.79: 5.01 | 63.22 | 0.001 |
Group 2 | 7.04 ± 1.02 | 3.60 ± 1.38 | 3.44 | 2.83: 4.05 | 48.86 | 0.001 |
MD | −0.08 | −1.04 | ||||
95% CI | −0.72: 0.56 | −1.79: −0.29 | ||||
p = 0.80 | p = 0.008 | |||||
ηπ2 | 0.14 | |||||
ODI (%) | ||||||
Group 1 | 32.84 ± 9.95 | 9.16 ± 4.33 | 23.68 | 20.13: 27.23 | 72.11 | 0.001 |
Group 2 | 33.60 ± 7.82 | 18.92 ± 4.01 | 14.68 | 11.13: 18.23 | 43.69 | 0.001 |
MD | −0.76 | −9.76 | ||||
95% CI | −5.85: 4.33 | −12.13: −7.39 | ||||
p = 0.77 | p = 0.001 | |||||
ηπ2 | 0.59 | |||||
Stability score (%) | ||||||
Group 1 | 45.46 ± 11.70 | 56.33 ± 10.52 | −10.87 | −13.04: −8.69 | 23.91 | 0.001 |
Group 2 | 43.25 ± 10.94 | 48.80 ± 12.55 | −5.55 | −7.72: −3.37 | 12.83 | 0.001 |
MD | 2.21 | 7.53 | ||||
95% CI | −4.23: 8.65 | 0.95: 14.12 | ||||
p = 0.49 | p = 0.02 | |||||
ηπ2 | 0.1 | |||||